You are here

Second Genome

Gilead to lean on Second Genome's microbiome work in $38M research pact

BioPharma Dive

Mon, 04/6/20 - 09:31 pm

Gilead Sciences

Microbiome Report for Week Ending 4/13/19

CP Wire

Thu, 04/18/19 - 10:33 pm

SkinBio Therapeutics

Netherton Syndrome

Microbiome Report for Week Ending 4/13/19

Thu, 04/18/19 - 10:31 pm

SkinBio Therapeutics

Netherton Syndrome

Microbiome Report for Week Ending 1/26/19

CP Wire

Tue, 01/29/19 - 03:39 pm

Vedanta Biosciences

Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial

CP Wire

Thu, 01/24/19 - 10:51 am

Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial

Thu, 01/24/19 - 10:12 am

Microbiome Report for Week Ending 9/29/18

CP Wire

Thu, 10/4/18 - 03:01 pm

Microbiome Report for Week Ending 9/29/18

Thu, 10/4/18 - 03:03 pm

The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019

CP Wire

Mon, 04/9/18 - 03:34 pm

The Great Drive to Develop Treatments for NASH continues with Second Genome Presenting Data Supporting Development of Its P2X7 Inhibitor, SGM-1019

Mon, 04/9/18 - 03:12 pm

Pfizer, Roche Embrace The Microbiome, Leading $43M Bet On Second Genome

Forbes

Wed, 04/20/16 - 09:49 pm

Pfizer jumps on the microbiome bandwagon with expansive Second Genome deal

Fierce Biotech

Fri, 05/2/14 - 11:29 am

Johnson & Johnson's Gut Feeling About the Future of Medicine

Motley Fool

Sat, 06/15/13 - 01:14 pm

Second Genome announces agreement with Janssen

Yahoo/Fly on the Wall

Wed, 06/5/13 - 12:27 pm